|
| |
Abbott Laboratories
| Headquarters location: 100 Abbott Park Road Abbott Park, IL 60064 |  | Tel. 847-937-6100 Job offers, investor relations: www.abbott.com Stock:  |
|
Abbott Laboratories belongs to |
| shareholder | country % source |
|
| subsidiary | country % source |
|
|
name  items photo compare the prices |
Shop local, ethical and at the best price on Ethishop ! |
|
|
« ETHICAL » RATING OF ABBOTT_LABORATORIES
, group
and subsidiaries
[ ?] |
| Job: 4% of company's jobs cut since 1998 |
| Environment: 1 major pollution(s) |
| Delinquency: 2 act(s) of financial or trade delinquency |
| Tax haven, secret bank account, shell companies: operates in 11 offshore financial center(s) |
| Sales: more than 18 billion(s) dollars/euros in annual sales |
| Net profit: more than 15 billion(s) dollars/euros in cumulated net profit since 1998 |
| Top management: earns 449 times the median income in the United States (32000 US$/year) |
| Influence: 5 act(s) of direct corruption or lobbying |
| Advertising & marketing: 1 dubious practice(s) |
|
|
Relevance: business & market share |
year | business source |
| 2006 | World's sixth-largest medical equipment maker. | Les Echos  |
| 2006 | Abbott is the world's ninth-largest pharmaceutical group. | Les Echos |
|
World locations & Manufacturing |
Abbott Laboratories is managed by |
| year name | photo position; compensation source |
| 2002Freyman, Thomas |  Chief Financial Officer; salary: 2.34 million US$; stock-options: 0.14 million US$; |
| 2002Gonzalez, Richard | Chairman; salary: 9.7 million US$; stock-options: 1.13 million US$; |
| 2002White, Miles | Chief Executive Officer; salary: 14.36 million US$; stock-options: 0.03 million US$; |
| 1999White, Miles | Chief Executive Officer; salary: 5.19 million US$; |
|
| year | dubious practice : image source |
| 2004 | Arguable partnership: Don pour les victimes du tsunami: 4000000 de dollars: value: Humanitaire; | AFP |
|
|
| year | employees <> | social impact : country source |
| 2007 | -1200 | Closure/Bankruptcy: Abbott closes its Mervue Business Park facility in Galway and in Temecula, California because of excess manufacturing capacity worldwide.: Ireland | The Irish . |
| 1998 | 56236 | |  |
|
| year | country : consequences source |
| 1999 | : Cause la mort de 1,5 millions enfants chaque année | Unicef |
|
| year | purpose : intermediary/lobby : institution source |
| 2000 | Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate | Washington. |
| 2000 | Investment protection and market access (to Mexico and Canada through NAFTA), to Latin America (through FTAA). : Business Roundtable : : US government, senate, congress translate | Center for. |
| 2000 | Prevent binding regulation, co- or self-regulation instead. : American Chamber of Commerce's EU Committee : : European Commission translate | Corporate . |
| 1998 | Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 183 thousand US$ : US President, Congress, Senate translate | Center for. |
|
| year | financial misdemeanor | sales | income | | | source |
| 2003 |
Abbott to pay $622 million to settle civil and criminal investigations into marketing practices and Medicare and Medicaid reimbursements. |
| | | | | | Bloomberg |
| 2002 |
| 17.68 | 2.79 | | | billion US$ | |
| 2001 |
| 16.29 | 1.55 | | | billion US$ | |
| 2001 |
TAP Pharmaceuticals Products fined a record Dollars 875m for fraudulently pricing and marketing of a cancer drug. |
| | | | | | Financial . |
| 2000 |
| 13.75 | 2.79 | | | billion US$ | |
| 1999 |
| 13.18 | 2.45 | | | billion US$ | |
| 1998 |
| 12.48 | 2.33 | | | billion US$ | |
|
|
|
|
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.